| Prev Close | 115.49 |
| Open | 115.08 |
| Day Low/High | 114.71 / 116.15 |
| 52 Wk Low/High | 84.64 / 132.13 |
| Volume | 2.45M |
| Avg Volume | 4.96M |
Eli Lilly & Co. (LLY)
115.63
0.14
0.12
NYSE : Health Technology
| Exchange | NYSE |
| Shares Outstanding | 970.83M |
| Market Cap | 112.19B |
| EPS | 3.10 |
| P/E Ratio | 44.45 |
| Div & Yield | 2.58 (2.10%) |
Lilly Is Testing Old Resistance
Stock is neither bullish nor bearish right now.
Watch: Jim Cramer Reveals His Outlook for Eli Lilly and Bristol Myers
Eli Lilly is a holding of Jim Cramer's charitable trust, Action Alerts PLUS.
Cramer: Is There a Human Element to This Rally?
It could be all machine-to-machine and not much more than that.
Eli Lilly Still Looking for Lower Prices
The charts don't look positive for drug company Eli Lilly.
Cramer: Got the Apple-FANG Blues? Look for a Rotation
There's one going on now.
Is Lilly Headed for the Valley?
The path of least resistance for LLY is lower.
Some Weak Names Today
An old trading dictim is that you might consider selling or shorting stocks that are in the red when the market is broadly in the green (and vice versa). Some conspicuous stocks that are weak today include Comcast , Gilead , Sprint , and Lilly .
Stocks Seesaw as U.S. Prepares for Hurricane Irma and Recovers From Harvey
Stocks struggled for direction through the morning session as Hurricane Irma approached the U.S. mainland even as Texas and Louisiana continued recovery efforts after Hurricane Harvey.
Merck Is Benefiting From Keytruda, but Jim Cramer Prefers Eli Lilly
Merck vs. Eli Lilly.
Here's What Up (and Down)
After 90 minutes of trading here are some market features: * Bonds are getting schmeissed. The 10-year U.S. note yield is close to 2.32% and the long bond is knocking on the door of 3.00%. A possible equity market headwind. * Retail still has a ni...
Biotech Sees Sharp Reversal
Biotech, as represented by iShares Nasdaq Biotechnology Index Fund , universally beloved by technicians and "talking heads" has just suffered an abrupt intraday turnaround. There may be a lesson here -- that charts often tell us where stocks have be...
Wall Street Preview: Tech Stocks and Oil in Focus
Investors digest earnings from Alphabet Inc and Eli Lilly & Co.
The Dow Binges on Earnings
Get ready for another heavy earnings slate
Earnings and Sentiment Boost Markets
Investors return to risk markets
2 Animal Drugmakers Worth a Sniff
Aratana Therapeutics and Kindred Biosciences are promising drug developers in the pet space.
Cramer: 10 Reasons for Today's Rally
Days like this remind you why you stay in.
Cramer: Stop Talking About the 'Market'
It just isn't as useful or descriptive right now.
Cramer: You Can't Bet Against the Bonds
A rotation that started as the minor chord of the rotational symphony and is now the major one.
Cramer: The Rotation Out of Apple and Nvidia Can Happen Again Today
We forget that a big hedge fund or mutual fund switching out of tech winners into everything else can roil the market.
Cramer: 15 Stocks to Buy for the Triathlon of Fear Coming on Super-Thursday
The handwringers will be out in full force. Their fear creates buying opportunities.
Lilly Is Wilting
Struggling stock is downgraded.
The Good, the Bad and the Ugly (Boring Edition)
"There are two kinds of spurs, my friend. Those that come in by the door; those that come in by the window.." -- Tuco, " The Good, the Bad and the Ugly" No "Takeaways" today as the action was kinda boring, uneventful and with little individual stock...
Takeaways and Observations
"She's a witch of trouble in electric blue, In her own mad mind she's in love with you. With you. Now what you gonna do? Strange brew, kill what's inside of you." -- Cream, Strange Brew Strange brew! You have probably forgotten October, 1987....
Radius Gives up Gains From Drug Approval
Been two fairly uneventful days of trading, as far as the market indexes go, sitting in for Doug Kass here on the Daily Diary. Major indices are slightly down as we head into the last two hours of the trading week. Getting a few questions on Radius ...
The Good, the Bad and the Ugly (Mid-Afternoon Edition)
"It's not a joke, it's a rope, Tuco. Now I want you to get up there and put your head in that noose." -- Blondie, " The Good, the Bad and the Ugly" No "Takeaways" today as I have to prepare for my Tulane trip. So let's move to the abbreviated Monarc...
Today's Takeaways and Observations (3PM Edition)
I spent a lot of time on the (respectful) Rosenberg/Kass debate on economic growth and interest rates today: * And Now A Word From Dennis Rosenberg * And Now A Word From Dennis Rosenberg (Part Deux) * And the Rosenberg Empire Strikes Again * Ju...
Closing Bell: Stocks End Higher As Corporate Earnings Take Focus
Stocks remained in positive territory breaking a three-day losing streak ahead of U.S. corporate earnings this week, despite mounting tension between North Korea and the U.S.
Takeaways and Observations (3PM Edition)
I started the day with an important piece on bonds - at least I hope so. Sell 'em, short 'em! Trade of the Week - long TBT (consistent with above). Well off the opening, at $37.60 now - and that's a good thing. So far, so good. At 230PM yield...
Stocks That Are Changing Direction
These charts are showing bullish or bearish reversals.
Cramer: Have Faith in International Strength
Because there are other things that will take the wind out of your sails.
